Volume 26, Number 7—July 2020
Synopsis
Public Health Role of Academic Medical Center in Community Outbreak of Hepatitis A, San Diego County, California, USA, 2016–2018
Minji Kang, Sarah F. Horman, Randy A. Taplitz, Brian Clay, Marlene Millen, Amy Sitapati, Frank E. Myers, Eric C. McDonald, Shira R. Abeles, Danelle R. Wallace, Sarah Stous, and Francesca J. Torriani
Table 2
Characteristics of adults receiving hepatitis A virus vaccine administered at University of California San Diego Health, March 1, 2017–October 31, 2018*
| Characteristic | No. vaccines administered |
||
|---|---|---|---|
| Hepatitis A, n = 9,288 | Hepatitis A and hepatitis B, recombinant, n = 1,036 | Total (%), N = 10,324 | |
| Location administered | |||
| Inpatient admission | 135 | 4 | 139 (1) |
| Urgent care | 1,091 | 117 | 1,208 (12) |
| Ambulatory clinic | 6,818 | 882 | 7,700 (75) |
| Occupational health | 865 | 96 | 961 (9) |
| ED BPA triggered |
1,369 |
5 |
1,374 (13) |
| Risk factors | |||
| Homelessness | 1,357 | 28 | 1,385 (13) |
| Illicit drug use | 2,247 | 230 | 2,477 (24) |
| Alcohol abuse | 873 | 97 | 970 (9) |
| Hepatitis C infection | 55 | 49 | 104 (1) |
| Hepatitis B infection | 0 | 0 | 0 (0) |
| HIV infection | 444 | 141 | 585 (6) |
| Cirrhosis | 411 | 127 | 538 (5) |
*ED, emergency department; BPA, best practice advisory.
Page created: April 10, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.